Clinical trials
Recruiting Inflammation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
394 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 6 |
| 2020 | 8 |
| 2021 | 26 |
| 2022 | 29 |
| 2023 | 44 |
| 2024 | 67 |
| 2025 | 113 |
| 2026 | 78 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 394 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 6 |
| Universidade Federal Fluminense | 6 |
| Assistance Publique - Hôpitaux de Paris | 5 |
| King's College London | 4 |
| Massachusetts General Hospital | 4 |
| Universitaire Ziekenhuizen KU Leuven | 4 |
| University of Aarhus | 4 |
| University of California, Davis | 4 |
| VA Office of Research and Development | 4 |
| Ain Shams University | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 394 |
| Obesity | 30 |
| Cardiovascular Diseases | 14 |
| Coronary Artery Disease | 14 |
| Metabolic Syndrome | 14 |
| Overweight | 12 |
| Diabetes Mellitus, Type 2 | 11 |
| Infections | 11 |
| Insulin Resistance | 11 |
| Major Depressive Disorder | 10 |
Trials
Showing 1 to 25 of 394. Each trial links to its page on Pharma Observatory.
294 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.